Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Preusser

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Der Radiologe|August 16, 2017
[Basic principles: signaling pathways and checkpoints]M Preusser
Der Nervenarzt|May 21, 2015
[Therapeutic options for brain metastases]M Preusser, F Winkler
Clinical Neuropathology|September 30, 2011
IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committeeM Preusser, D Capper, C Hartmann, et al.
ESMO Open|July 7, 2022
Introducing pro and con discussions in ESMO Open-Cancer HorizonsC Zielinski, M Preusser, A Berghoff
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|April 2, 2011
Ascending aortic aneurysm causing orthodeoxy-platypnoe syndromeM Preusser, T Binder, G Goliasch
ESMO Open|December 16, 2023
ESMO Open: from Cancer Horizons to Science for Optimal Cancer Care-a tale stretching over 8 yearsC Zielinski, M Preusser, A Berghoff
Clinical Neuropathology|December 8, 2004
Algorithm for the standardized assessment of vascular patterns in glioblastoma specimensM Preusser, P Birner, J A Hainfellner
Clinical Neuropathology|January 10, 2009
Reliability and reproducibility of PCR-based testing of O6-methylguanine-DNA methyltransferase gene (MGMT) promoter methylation status in formalin-fixed and paraffin-embedded neurosurgical biopsy specimensM Preusser, L Elezi, J A Hainfellner
ESMO Open|April 16, 2025
Response to letter re: Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022H C Puhr, E C Winkler, M Preusser
ESMO Open|January 4, 2025
Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022H C Puhr, E C Winkler, M Preusser
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Der Radiologe|August 16, 2017
[Basic principles: signaling pathways and checkpoints]M Preusser
Der Nervenarzt|May 21, 2015
[Therapeutic options for brain metastases]M Preusser, F Winkler
Clinical Neuropathology|September 30, 2011
IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committeeM Preusser, D Capper, C Hartmann, et al.
ESMO Open|July 7, 2022
Introducing pro and con discussions in ESMO Open-Cancer HorizonsC Zielinski, M Preusser, A Berghoff
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|April 2, 2011
Ascending aortic aneurysm causing orthodeoxy-platypnoe syndromeM Preusser, T Binder, G Goliasch
ESMO Open|December 16, 2023
ESMO Open: from Cancer Horizons to Science for Optimal Cancer Care-a tale stretching over 8 yearsC Zielinski, M Preusser, A Berghoff
Clinical Neuropathology|December 8, 2004
Algorithm for the standardized assessment of vascular patterns in glioblastoma specimensM Preusser, P Birner, J A Hainfellner
Clinical Neuropathology|January 10, 2009
Reliability and reproducibility of PCR-based testing of O6-methylguanine-DNA methyltransferase gene (MGMT) promoter methylation status in formalin-fixed and paraffin-embedded neurosurgical biopsy specimensM Preusser, L Elezi, J A Hainfellner
ESMO Open|April 16, 2025
Response to letter re: Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022H C Puhr, E C Winkler, M Preusser
ESMO Open|January 4, 2025
Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022H C Puhr, E C Winkler, M Preusser
Pageof 7